Home › NDC Lookup › RxCUI directory › RxCUI 1191309

Fluocinolone acetonide 0.1 MG/ML Topical Oil [Derma-Smoothe FS] — RxCUI 1191309

RxNorm drug concept · Semantic branded drug
RxCUI 1191309 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1191309
Official nameFluocinolone acetonide 0.1 MG/ML Topical Oil [Derma-Smoothe FS]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDerma-Smoothe/FS 0.01 % Topical Oil; Derma-Smoothe/FS Scalp 0.01 % Topical Oil; Derma-Smoothe/FS 0.1 MG/ML Topical Oil
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)94,190 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluocinolone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The fluocinolone acetonide oil covered here treats atopic dermatitis (eczema) in adults. It is also used for moderate to severe eczema in children 3 months and older, for up to 4 w...
  • Use a thin film on the affected skin only, and just enough to cover it. Adults use it about three times a day. For children, moisten the skin first and apply about twice a day. Kee...
  • Not unless your doctor directs it. Avoid the face, underarms, groin and skin folds. Never use it in the diaper area, because diapers can increase how much is absorbed.
  • Can I put it on my face or my baby's diaper area?
📖 Read our full Fluocinolone Topical guide →

🕸️ Concept Web — How Fluocinolone acetonide 0.1 MG/ML Topical Oil [De... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluocinolone acetonide 0.1 MG/ML Topical Oil [Derma-Smoothe FS] RxCUI 1191309

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Fluocinolone 25126
    • Fluocinolone acetonide 4461
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Derma-Smoothe FS 352578
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluocinolone Topical Oil 385106
    • Fluocinolone acetonide Topical Oil 2648282
    • Fluocinolone Topical Product 1165646
    • Fluocinolone acetonide Topical Product 2661133
    • Fluocinolone Topical Oil [Derma-Smoothe FS] 361009
    • Fluocinolone acetonide Topical Oil [Derma-Smoothe FS] 2658931
    • Derma-Smoothe FS Topical Product 1173136
    • Topical Oil 316984
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluocinolone acetonide 0.1 MG/ML Topical Oil SCD · 1191307
  • Fluocinolone acetonide 0.1 MG/ML SCDC · 1191261
  • Fluocinolone Topical Oil SCDF · 385106
  • Fluocinolone acetonide Topical Oil SCDFP · 2648282
  • Fluocinolone Topical Product SCDG · 1165646
  • Fluocinolone acetonide Topical Product SCDGP · 2661133

Brand-Name Concepts

  • Fluocinolone acetonide 0.1 MG/ML [Derma-Smoothe FS] SBDC · 1191308
  • Fluocinolone Topical Oil [Derma-Smoothe FS] SBDF · 361009
  • Fluocinolone acetonide Topical Oil [Derma-Smoothe FS] SBDFP · 2658931
  • Derma-Smoothe FS Topical Product SBDG · 1173136
  • Derma-Smoothe FS BN · 352578

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1191309 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68791-0101-04 1 BOTTLE in 1 CARTON (68791-101-04) / 118.28 mL in 1 BOTTLE Derma-Smoothe/FS Royal Pharmaceuticals, LLC 1995-02-16
68791-0102-04 1 BOTTLE in 1 CARTON (68791-102-04) / 118.28 mL in 1 BOTTLE DERMA-SMOOTHE/FS Royal Pharmaceuticals 1995-02-16
Observed labelers: Royal Pharmaceuticals (1) · Royal Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.2424
Range $0.2423–$0.2426 · middle 50% $0.2423–$0.2425 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.